欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2755/001
药品名称
Tanafra
活性成分
Latanoprost 50.0 µg/l
剂型
Eye drops, solution
上市许可持有人
Pharmathen S.A. 6, Dervenakion str. 153 51 Pallini, Attiki Greece
参考成员国 - 产品名称
Denmark (DK)
Tanafra
互认成员国 - 产品名称
France (FR)
Spain (ES)
Italy (IT)
Greece (GR)
Cyprus (CY)
TANAFRA 50MCG/ML EYE DROPS
许可日期
2018/05/24
最近更新日期
2024/11/29
药物ATC编码
S01EE01 latanoprost
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
2755 common_pil_iain009_clean
Date of last change:2024/09/06
Final SPC
|
2755 common_spc_iain009_clean
Date of last change:2024/09/06
Final Labelling
|
common_label_clean_ib010
Date of last change:2024/09/06
PubAR
|
Scientific discussion_PAR_latanoprost eyedrops_Tanafra
Date of last change:2024/09/06
PubAR Summary
|
Summary public assessment report_latanoprost eyedrops_Tanafra
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase